Eastern Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Buy |
1,635
+25
| +2% | +$11.1K | 0.01% | 211 |
|
|
2025
Q1 | $781K | Sell |
1,610
-10
| -0.6% | -$4.85K | 0.02% | 222 |
|
|
2024
Q4 | $652K | Sell |
1,620
-111
| -6% | -$44.7K | 0.01% | 248 |
|
|
2024
Q3 | $805K | Buy |
+1,731
| New | +$805K | 0.01% | 239 |
|
|
2021
Q3 | – | Sell |
-3,300
| Closed | -$665K | – | 193 |
|
|
2021
Q2 | $665K | Hold |
3,300
| – | – | 0.03% | 145 |
|
|
2021
Q1 | $709K | Hold |
3,300
| – | – | 0.04% | 137 |
|
|
2020
Q4 | $780K | Hold |
3,300
| – | – | 0.04% | 127 |
|
|
2020
Q3 | $898K | Sell |
3,300
-15
| -0.5% | -$4.08K | 0.06% | 117 |
|
|
2020
Q2 | $962K | Hold |
3,315
| – | – | 0.06% | 113 |
|
|
2020
Q1 | $789K | Hold |
3,315
| – | – | 0.06% | 115 |
|
|
2019
Q4 | $726K | Hold |
3,315
| – | – | 0.04% | 117 |
|
|
2019
Q3 | $562K | Hold |
3,315
| – | – | 0.04% | 130 |
|
|
2019
Q2 | $608K | Hold |
3,315
| – | – | 0.04% | 128 |
|
|
2019
Q1 | $610K | Hold |
3,315
| – | – | 0.04% | 132 |
|
|
2018
Q4 | $549K | Buy |
3,315
+1,000
| +43% | +$166K | 0.04% | 134 |
|
|
2018
Q3 | $446K | Buy |
+2,315
| New | +$446K | 0.03% | 155 |
|